Results 101 to 110 of about 5,138,607 (284)

Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid

Scientific Reports, 2019
Bisphosphonates are frequently used for the antiresorptive treatment in bone metastasis diseases or for osteoporosis. A side effect of this therapy is osteonecrosis of the jaw.
D. Steller, Nele Herbst, R. Pries, D. Juhl, S. Hakim   +4 more
semanticscholar   +1 more source

Corrigendum: A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures [PDF]

, 2016
Background Fragility fractures are fractures that result from mechanical forces that would not ordinarily result in fracture. Objectives To evaluate the clinical effectiveness and safety of bisphosphonates [alendronic acid (Fosamax® and Fosamax ...
Abrahamsen, Achana, Actavis UK Ltd, Adachi, Adachi, Adami, Allaf, Andrici, Ara, Atmaca, Bianchi, Black, Black, Blank, Bobba, Bone, Bonjour, Bonnick, Boonen, Boonen, Borgström, Borgström, Borgström, Borgström, Brooks, Burge, Calvo, Carfora, Cauley, Center, Chesnut, Chesnut, Chesnut, Choo, Cockerill, Cohen, Commercial Medicines Unit, Compston, Cooper, Cooper, Court-Brown, Cramer, Crandall, Cummings, Curtis, Curtis, De Laet, Deakin, Deakin, Delmas, Department of Health, Dias, Dias, Dias, Dolan, Dursun, Eisman, Ekström, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, European Medicines Agency, European Medicines Agency, EuroQoL-Group, Evans, Fardet, Felsenberg, Fogelman, Gauthier, Gedmintas, Genant, Giusti, Gleason, Goldacre, Greenspan, Greenspan, Groeneveld, Gutierrez, Gutierrez, Guyatt, Hadji, Hadji, Haentjens, Hagino, Harris, Harris, Haymarket Medical Media, Health & Social Care Information Centre, Heikkinen, Hernlund, Higgins, Hippisley-Cox, Hippisley-Cox, Ho, Hofman, Holt, Holt, Holt, Hooper, Hospira UK Ltd, Humphries, Idris, Imaz, Ismail, Jalava, Johansson, Johnell, Joint Formulary Committee, Joint Formulary Committee, Kado, Kado, Kanis, Kanis, Kanis, Kanis, Kanis, Kanis, Kanis, Kanis, Kherani, Klevsgård, Klotz, Klotzbuecher, Koerkamp, Kothawala, Krueger, Lee, Lee, Lester, Lester, Leung, Liberman, Lips, Lloyd-Jones, Loke, Lunn, Lyles, Marsh, Martyn-St James, McClung, McClung, McClung, McColl, Mikyas, Miller, Miller, Moher, Muscoso, Müller, Nanjayan, National Collaborating Centre for Nursing and Supportive Care, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Osteoporosis Society, Nguyen, NHS Prescription Servcies, Oden, Office for National Statistics, Office for National Statistics, Office for National Statistics, Office for National Statistics, Office of Disease Prevention, Orwoll, Orwoll, Osnes, Parker, Pasco, Peasgood, Philips, Piirtola, Pols, Preferred Reporting Items for Systematic Reviews and Meta-analyses, Prescribing and Primary Care Team Health and Social Care Information Centre, Prescribing Team Health and Social Care Information Centre, Ralston, Reginster, Reginster, Reid, Reid, Reid, Reid, Reid, Ringe, Ringe, Rizzoli, Roberts, Rosen, Roux, Saag, Sarioglu, Scholes, Seeman, Shilbayeh, Smith, Smith, Sorensen, Spiegelhalter, Ste-Marie, Stevenson, Stevenson, Stevenson, Stevenson, Ström, Ström, Ström, Sturtz, Sun, Suzuki, Suzuki, Szende, Tadic, Taxel, The Care Quality Commission, Tidermark, Tidermark, Todd, Tosteson, Umland, Van den Wyngaert, van Geel, van Hoek, van Schoor, van Staa, van Staa, van Staa, van Staa, Vieira, Wade, Warriner, Woo, Wood, World Health Organization (WHO) Study Group, Wright, Zethraeus, Zethraeus   +244 more
core   +2 more sources

Alterations of bone proteins in medication‐related osteonecrosis of the jaw

European Journal of Oral Sciences, Volume 133, Issue 2, April 2025.
Abstract Changes in the protein expression pattern of osteoblastic lineage cells from the alveolar bone (OLAB) during medication‐related osteonecrosis of the jaw (MRONJ) have rarely been investigated. This lack of information is partly because of the limited availability of healthy samples and the lack of human alveolar bone cell lines for research ...
Andrea Schubert, Phillipp Brockmeyer, Philipp Kauffmann, Jan Wiegel, Florian Lautenbacher, Nicolai Miosge, Boris Schminke   +6 more
wiley   +1 more source

Codelivery of zoledronic acid and double-stranded RNA from core-shell nanoparticles

International Journal of Nanomedicine, 2013
Li Chen,1 Yunfei Ding,2 Yongzhong Wang,3 Xingrong Liu,2 RJ Babu,1 WR Ravis,1 Weili Yan21Department of Pharmaceutical Sciences, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA; 2Department of Pharmaceutical Sciences, College of Life ...
Yan W, Ravis WR, Babu RJ, Liu X, Wang Y, Ding Y, Chen L   +6 more
doaj  

Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study—Asian Subgroup Analysis

Advances in Therapy, 2020
Introduction The primary analysis of a global phase 3 study that evaluated the efficacy and safety of denosumab versus zoledronic acid for preventing skeletal-related events (SREs) in adults with newly diagnosed multiple myeloma (MM) indicated that ...
Shang‐Yi Huang, S. Yoon, K. Shimizu, W. Chng, Cheng-Shyong Chang, R. Wong, Seasea Gao, Yang Wang, Steve W. Gordon, A. Glennane, C. Min   +10 more
semanticscholar   +1 more source

Effect of metformin on inflammation and bone damage in a rat model of medication‐related osteonecrosis of the jaw

European Journal of Oral Sciences, EarlyView.
Abstract This study investigated how chronic metformin administration modulates the cellular profile and inflammatory markers in a zoledronic acid‐based rat model of medication‐related osteonecrosis of the jaw (MRONJ). Male Wistar rats were allocated to different treatments: (i) naïve, (ii) MRONJ (zoledronic acid, 0.2 mg/kg, i.v.
Liviane Maria Alves Rabelo, Mariana Vasconcelos Guimarães, Aurilene Gomes Cajado, José Vitor Mota Lemos, Felipe Domingos de Sousa, Nylane Maria Nunes Alencar, Vilma de Lima, Paulo Goberlânio de Barros Silva, Ana Paula Negreiros Nunes Alves, Deysi Viviana Tenazoa Wong, Roberto César Pereira Lima‐Júnior   +10 more
wiley   +1 more source

Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial

Journal of Bone Oncology, 2019
Background: Although denosumab has been approved as an antiresorptive agent for giant cell tumor of bone, its efficacy has not been proven. Objectives: To compare the efficacy and safety of denosumab and zoledronic acid treatment in patients with ...
Shenglong Li, Peng Chen, Qiankun Yang
doaj   +1 more source

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis [PDF]

, 2012
Recent data from the AZURE, ABCSG-12, and ZO-FAST clinical trials have challenged our understanding of the potential anticancer activity of zoledronic acid (ZOL). Although the results of these studies may appear to be conflicting on the surface, a deeper
Arrington, Avcu, Baum, Bilezikjian, Binkley, Bismar, Black, Bourdeau, Brown, Bundred, Burger, Burger, Centrella, Chapman, Cheleuitte, Chiu, Clowes, Coleman, Coscia, Coxon, Croucher, de Boer, Del Mastro, Dixon, Duivenvoorden, Edlund, Edlund, Esparza-Lopez, Folkerd, Gasser, Gasser, Geisler, Giraudo, Gnant, Gnant, Gnant, Gnant, Gordon, Guo, Hackshaw, Hamilton, Hampl, Hershman, Hershman, Hines, Hiraga, Hofbauer, Hornby, Ibrahim, Jimenez-Gordo, Juarez, Kaplan, Kaplan, Kardassis, Khosla, Kirkbride, Labrinidis, Le Goff, Lee, Lewis, Lindberg, Little, Little, Meads, Melani, Monkkonen, Muller, Nicks, Ogata, Ottewell, Ottewell, Ottewell, Pataki, Perrien, Perrien, Peyruchaud, Pfeilschifter, Podworny, Rachner, Rannevik, Roelofs, Rogers, Rosen, Rosen, Saika, Sasser, Sasser, Shiozawa, Shipman, Sims, Sirola, Skerjanec, Sowers, Studebaker, Sun, Tang, Thompson, Thurlimann, Uncu, van de Velde, Weiss, Wels, Welt, Wiater, Winter   +104 more
core   +1 more source

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

Internal Medicine Journal, EarlyView.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley, Marianne S Elston, Ben Lawrence, Veronica Boyle   +3 more
wiley   +1 more source

Zoledronic acid induced unilateral anterior uveitis

Indian Journal of Ophthalmology, 2020
Zoledronic acid is recommended for patients with osteoporosis. To report a case of unilateral anterior uveitis after zoledronate infusion. An osteoporotic patient presented with pain, visual loss, hyperemia, photophobia, and watering from the left eye ...
Shipra Gupta, Abhishek Onkar, Tushar Vashisht   +2 more
semanticscholar   +1 more source